Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation

Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunoco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology (Baltimore, Md.) Md.), 1999-12, Vol.30 (6), p.1513-1520
Hauptverfasser: Pessoa, Mario G., Bzowej, Natalie, Berenguer, Marina, Phung, Yume, Kim, Michael, Ferrell, Linda, Hassoba, Howayda, Wright, Teresa L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1520
container_issue 6
container_start_page 1513
container_title Hepatology (Baltimore, Md.)
container_volume 30
creator Pessoa, Mario G.
Bzowej, Natalie
Berenguer, Marina
Phung, Yume
Kim, Michael
Ferrell, Linda
Hassoba, Howayda
Wright, Teresa L.
description Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.
doi_str_mv 10.1002/hep.510300610
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69302953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69302953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</originalsourceid><addsrcrecordid>eNp90DFv2zAQBWCiaNE4aceuAYeim9Ijj7SsMTCcJkCAdmhngaKOMAtZUniSg_z70LCRZMrE4T483j0hvim4UgD655bGK6sAAZYKPoiFsrosEC18FAvQJRSVwupMnDP_B4DK6NVncabAlmhRL8S82Q_dPMWhl0OQOcxNcYos13If08zyYXYceSQfiWXs5WFO_cTyMU5bybSnRNJvh454yiP_JsKFiZLsYiZySq7nsXP9AQ39F_EpuI7p6-m9EP9uNn_Xt8X971936-v7whs0UJgSTekbCJpaZSw43ZTtaqWhcdau2qbxBtolOm19GxrlPeqAtqGAS4NYebwQP465Yxoe5rxivYvsqcuL0DBzvawQdGUxw-IIfRqYE4V6THHn0lOtoD70XOe76pees788Bc_Njto3-lhsBt9PwLF3Xcj3-8ivTlVgwWRWHtlj7Ojp_U_r282f1w2eAdpbmJo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69302953</pqid></control><display><type>article</type><title>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Pessoa, Mario G. ; Bzowej, Natalie ; Berenguer, Marina ; Phung, Yume ; Kim, Michael ; Ferrell, Linda ; Hassoba, Howayda ; Wright, Teresa L.</creator><creatorcontrib>Pessoa, Mario G. ; Bzowej, Natalie ; Berenguer, Marina ; Phung, Yume ; Kim, Michael ; Ferrell, Linda ; Hassoba, Howayda ; Wright, Teresa L.</creatorcontrib><description>Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.510300610</identifier><identifier>PMID: 10573532</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>Philadelphia, PA: W.B. Saunders</publisher><subject>Biological and medical sciences ; Cholestasis, Intrahepatic - pathology ; Cholestasis, Intrahepatic - virology ; Disease Progression ; DNA Mutational Analysis ; Evolution, Molecular ; Genetic Variation - genetics ; Hepacivirus - genetics ; Hepacivirus - immunology ; Hepacivirus - physiology ; Hepatitis C - pathology ; Hepatitis C - therapy ; Hepatitis C - virology ; Human viral diseases ; Humans ; Immunosuppression - adverse effects ; Infectious diseases ; Liver - pathology ; Liver - virology ; Liver Transplantation - adverse effects ; Medical sciences ; Phylogeny ; Recurrence ; Time Factors ; Viral diseases ; Viral diseases of the digestive system</subject><ispartof>Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1513-1520</ispartof><rights>Copyright © 1999 American Association for the Study of Liver Diseases</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</citedby><cites>FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.510300610$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.510300610$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1190504$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10573532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pessoa, Mario G.</creatorcontrib><creatorcontrib>Bzowej, Natalie</creatorcontrib><creatorcontrib>Berenguer, Marina</creatorcontrib><creatorcontrib>Phung, Yume</creatorcontrib><creatorcontrib>Kim, Michael</creatorcontrib><creatorcontrib>Ferrell, Linda</creatorcontrib><creatorcontrib>Hassoba, Howayda</creatorcontrib><creatorcontrib>Wright, Teresa L.</creatorcontrib><title>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.</description><subject>Biological and medical sciences</subject><subject>Cholestasis, Intrahepatic - pathology</subject><subject>Cholestasis, Intrahepatic - virology</subject><subject>Disease Progression</subject><subject>DNA Mutational Analysis</subject><subject>Evolution, Molecular</subject><subject>Genetic Variation - genetics</subject><subject>Hepacivirus - genetics</subject><subject>Hepacivirus - immunology</subject><subject>Hepacivirus - physiology</subject><subject>Hepatitis C - pathology</subject><subject>Hepatitis C - therapy</subject><subject>Hepatitis C - virology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunosuppression - adverse effects</subject><subject>Infectious diseases</subject><subject>Liver - pathology</subject><subject>Liver - virology</subject><subject>Liver Transplantation - adverse effects</subject><subject>Medical sciences</subject><subject>Phylogeny</subject><subject>Recurrence</subject><subject>Time Factors</subject><subject>Viral diseases</subject><subject>Viral diseases of the digestive system</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90DFv2zAQBWCiaNE4aceuAYeim9Ijj7SsMTCcJkCAdmhngaKOMAtZUniSg_z70LCRZMrE4T483j0hvim4UgD655bGK6sAAZYKPoiFsrosEC18FAvQJRSVwupMnDP_B4DK6NVncabAlmhRL8S82Q_dPMWhl0OQOcxNcYos13If08zyYXYceSQfiWXs5WFO_cTyMU5bybSnRNJvh454yiP_JsKFiZLsYiZySq7nsXP9AQ39F_EpuI7p6-m9EP9uNn_Xt8X971936-v7whs0UJgSTekbCJpaZSw43ZTtaqWhcdau2qbxBtolOm19GxrlPeqAtqGAS4NYebwQP465Yxoe5rxivYvsqcuL0DBzvawQdGUxw-IIfRqYE4V6THHn0lOtoD70XOe76pees788Bc_Njto3-lhsBt9PwLF3Xcj3-8ivTlVgwWRWHtlj7Ojp_U_r282f1w2eAdpbmJo</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>Pessoa, Mario G.</creator><creator>Bzowej, Natalie</creator><creator>Berenguer, Marina</creator><creator>Phung, Yume</creator><creator>Kim, Michael</creator><creator>Ferrell, Linda</creator><creator>Hassoba, Howayda</creator><creator>Wright, Teresa L.</creator><general>W.B. Saunders</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199912</creationdate><title>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</title><author>Pessoa, Mario G. ; Bzowej, Natalie ; Berenguer, Marina ; Phung, Yume ; Kim, Michael ; Ferrell, Linda ; Hassoba, Howayda ; Wright, Teresa L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4340-47347cb0f2ed1450a2b7d8820ba558dbbc40d63a25cdfb1cc32f35bef364339c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Cholestasis, Intrahepatic - pathology</topic><topic>Cholestasis, Intrahepatic - virology</topic><topic>Disease Progression</topic><topic>DNA Mutational Analysis</topic><topic>Evolution, Molecular</topic><topic>Genetic Variation - genetics</topic><topic>Hepacivirus - genetics</topic><topic>Hepacivirus - immunology</topic><topic>Hepacivirus - physiology</topic><topic>Hepatitis C - pathology</topic><topic>Hepatitis C - therapy</topic><topic>Hepatitis C - virology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunosuppression - adverse effects</topic><topic>Infectious diseases</topic><topic>Liver - pathology</topic><topic>Liver - virology</topic><topic>Liver Transplantation - adverse effects</topic><topic>Medical sciences</topic><topic>Phylogeny</topic><topic>Recurrence</topic><topic>Time Factors</topic><topic>Viral diseases</topic><topic>Viral diseases of the digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pessoa, Mario G.</creatorcontrib><creatorcontrib>Bzowej, Natalie</creatorcontrib><creatorcontrib>Berenguer, Marina</creatorcontrib><creatorcontrib>Phung, Yume</creatorcontrib><creatorcontrib>Kim, Michael</creatorcontrib><creatorcontrib>Ferrell, Linda</creatorcontrib><creatorcontrib>Hassoba, Howayda</creatorcontrib><creatorcontrib>Wright, Teresa L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pessoa, Mario G.</au><au>Bzowej, Natalie</au><au>Berenguer, Marina</au><au>Phung, Yume</au><au>Kim, Michael</au><au>Ferrell, Linda</au><au>Hassoba, Howayda</au><au>Wright, Teresa L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>1999-12</date><risdate>1999</risdate><volume>30</volume><issue>6</issue><spage>1513</spage><epage>1520</epage><pages>1513-1520</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>Evolution of hepatitis C quasispecies may be one mechanism by which fibrosing cholestatic hepatitis develops after liver transplantation. In this study, we compared changes in quasispecies complexity and/or divergence in (1) hepatitis C‐infected immunosuppressed transplant recipients and in immunocompetent controls; (2) transplant recipients with mild recurrence, and in those with the most severe form of posttransplantation recurrence. Quasispecies were measured in 12 hepatitis C‐infected patients pretransplantation and posttransplantation (6 with mild and 6 with severe recurrence), and in 5 immunocompetent patients with similar follow‐up, and characterized by heteroduplex mobility and sequence analysis of the hypervariable region. Although the number of variants (complexity) did not change with time in either group, there was a qualitative change in the variants with time (divergence) in immunocompromised, but not in immunocompetent patients. These changes were most marked with severe recurrence, and preceded the development of severe disease. Phylogenetic analysis confirmed that most posttransplantation variants were unrelated to those detected pretransplantation. These observations suggest that in the absence of immune suppression, there is minor evolution of quasispecies. With immune suppression, divergence of quasispecies is enhanced, resulting in selection/emergence of many new variants, particularly in those with fibrosing cholestatic hepatitis. Thus, quasispecies may influence disease progression in immune suppressed populations.</abstract><cop>Philadelphia, PA</cop><pub>W.B. Saunders</pub><pmid>10573532</pmid><doi>10.1002/hep.510300610</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-9139
ispartof Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1513-1520
issn 0270-9139
1527-3350
language eng
recordid cdi_proquest_miscellaneous_69302953
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Biological and medical sciences
Cholestasis, Intrahepatic - pathology
Cholestasis, Intrahepatic - virology
Disease Progression
DNA Mutational Analysis
Evolution, Molecular
Genetic Variation - genetics
Hepacivirus - genetics
Hepacivirus - immunology
Hepacivirus - physiology
Hepatitis C - pathology
Hepatitis C - therapy
Hepatitis C - virology
Human viral diseases
Humans
Immunosuppression - adverse effects
Infectious diseases
Liver - pathology
Liver - virology
Liver Transplantation - adverse effects
Medical sciences
Phylogeny
Recurrence
Time Factors
Viral diseases
Viral diseases of the digestive system
title Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A26%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20hepatitis%20C%20virus%20quasispecies%20in%20patients%20with%20severe%20cholestatic%20hepatitis%20after%20liver%20transplantation&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Pessoa,%20Mario%20G.&rft.date=1999-12&rft.volume=30&rft.issue=6&rft.spage=1513&rft.epage=1520&rft.pages=1513-1520&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1002/hep.510300610&rft_dat=%3Cproquest_cross%3E69302953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69302953&rft_id=info:pmid/10573532&rfr_iscdi=true